Vienna Versus SARS-CoV-2 Virus Study

NCT04407429 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2020-05-29

No results posted yet for this study

Summary

This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.

Conditions

Interventions

DIAGNOSTIC_TEST

Laboratory Analyses

Storage of serum for SARS-CoV-2-antibodies and biomarkers

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Christian Hengstenberg, Univ.-Prof. · Medical University of Vienna

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-27
Primary Completion
2021-06-27
Completion
2021-06-27

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407429 on ClinicalTrials.gov